These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 8472628)

  • 1. Clinical evaluation of biosynthetic glucagon treatment for recovery from hypoglycemia developed in diabetic patients. The GL-G Hypoglycemia Study Group.
    Namba M; Hanafusa T; Kono N; Tarui S
    Diabetes Res Clin Pract; 1993 Feb; 19(2):133-8. PubMed ID: 8472628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal glucagon for hypoglycaemia in diabetic patients. An old dream is becoming reality?
    Pontiroli AE; Ceriani V
    Diabetes Obes Metab; 2018 Aug; 20(8):1812-1816. PubMed ID: 29652110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal glucagon as remedy for hypoglycemia. Studies in healthy subjects and type I diabetic patients.
    Pontiroli AE; Calderara A; Pajetta E; Alberetto M; Pozza G
    Diabetes Care; 1989 Oct; 12(9):604-8. PubMed ID: 2676430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GLUCAGON PRESCRIPTIONS FOR DIABETES PATIENTS AFTER EMERGENCY DEPARTMENT VISITS FOR HYPOGLYCEMIA.
    Fendrick AM; He X; Liu D; Buxbaum JD; Mitchell BD
    Endocr Pract; 2018 Oct; 24(10):861-866. PubMed ID: 30035620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New Fast Acting Glucagon for Recovery from Hypoglycemia, a Life-Threatening Situation: Nasal Powder and Injected Stable Solutions.
    La Sala L; Pontiroli AE
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nasal glucagon in the treatment of hypoglycaemia in type 1 (insulin-dependent) diabetic patients.
    Rosenfalck AM; Bendtson I; Jørgensen S; Binder C
    Diabetes Res Clin Pract; 1992 Jul; 17(1):43-50. PubMed ID: 1511660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prehospital treatment of severe hypoglycaemia: a comparison of intramuscular glucagon and intravenous glucose.
    Carstens S; Sprehn M
    Prehosp Disaster Med; 1998; 13(2-4):44-50. PubMed ID: 10346406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal glucagon: a promising approach for treatment of severe hypoglycemia.
    Pontiroli AE
    J Diabetes Sci Technol; 2015 Jan; 9(1):38-43. PubMed ID: 25385946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alanine and terbutaline in treatment of hypoglycemia in IDDM.
    Wiethop BV; Cryer PE
    Diabetes Care; 1993 Aug; 16(8):1131-6. PubMed ID: 8375243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Glucagon, the indispensable companion of the insulin injecting diabetic].
    Schaetz A
    Munch Med Wochenschr; 1967 Oct; 109(41):2134-6. PubMed ID: 5631696
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of subcutaneous, low-dose glucagon on insulin-induced mild hypoglycaemia in patients with insulin pump treated type 1 diabetes.
    Ranjan A; Schmidt S; Madsbad S; Holst JJ; Nørgaard K
    Diabetes Obes Metab; 2016 Apr; 18(4):410-8. PubMed ID: 26743775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonaqueous, Mini-Dose Glucagon for Treatment of Mild Hypoglycemia in Adults With Type 1 Diabetes: A Dose-Seeking Study.
    Haymond MW; Redondo MJ; McKay S; Cummins MJ; Newswanger B; Kinzell J; Prestrelski S
    Diabetes Care; 2016 Mar; 39(3):465-8. PubMed ID: 26861921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversing severe hypoglycemia during pregnancy with glucagon therapy.
    Rayburn W; Piehl E; Sanfield J; Compton A
    Am J Perinatol; 1987 Jul; 4(3):259-61. PubMed ID: 3300677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current practice of hypoglycemia management in the ED.
    Bilhimer MH; Treu CN; Acquisto NM
    Am J Emerg Med; 2017 Jan; 35(1):87-91. PubMed ID: 27832978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mini-dose glucagon rescue for hypoglycemia in children with type 1 diabetes.
    Haymond MW; Schreiner B
    Diabetes Care; 2001 Apr; 24(4):643-5. PubMed ID: 11315823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Safety of Mini-Dose Glucagon for Treatment of Nonsevere Hypoglycemia in Adults With Type 1 Diabetes.
    Haymond MW; DuBose SN; Rickels MR; Wolpert H; Shah VN; Sherr JL; Weinstock RS; Agarwal S; Verdejo AS; Cummins MJ; Newswanger B; Beck RW;
    J Clin Endocrinol Metab; 2017 Aug; 102(8):2994-3001. PubMed ID: 28591776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of intranasal glucagon on blood glucose levels in healthy subjects and hypoglycaemic patients with insulin-dependent diabetes.
    Freychet L; Rizkalla SW; Desplanque N; Basdevant A; Zirinis P; Tchobroutsky G; Slama G
    Lancet; 1988 Jun; 1(8599):1364-6. PubMed ID: 2898045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between Optimum Mini-doses of Glucagon and Insulin Levels when Treating Mild Hypoglycaemia in Patients with Type 1 Diabetes - A Simulation Study.
    Ranjan A; Wendt SL; Schmidt S; Madsbad S; Holst JJ; Madsen H; Knudsen CB; Jørgensen JB; Nørgaard K
    Basic Clin Pharmacol Toxicol; 2018 Mar; 122(3):322-330. PubMed ID: 28922582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic and Pharmacodynamic Characteristics of Dasiglucagon, a Novel Soluble and Stable Glucagon Analog.
    Hövelmann U; Bysted BV; Mouritzen U; Macchi F; Lamers D; Kronshage B; Møller DV; Heise T
    Diabetes Care; 2018 Mar; 41(3):531-537. PubMed ID: 29273578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of intravenous glucagon and dextrose in treatment of severe hypoglycemia in an accident and emergency department.
    Collier A; Steedman DJ; Patrick AW; Nimmo GR; Matthews DM; MacIntyre CC; Little K; Clarke BF
    Diabetes Care; 1987; 10(6):712-5. PubMed ID: 3428048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.